DK1200561T3 - Rekombinant stabil celleklon, dens fremstilling og anvendelse - Google Patents

Rekombinant stabil celleklon, dens fremstilling og anvendelse

Info

Publication number
DK1200561T3
DK1200561T3 DK99939251T DK99939251T DK1200561T3 DK 1200561 T3 DK1200561 T3 DK 1200561T3 DK 99939251 T DK99939251 T DK 99939251T DK 99939251 T DK99939251 T DK 99939251T DK 1200561 T3 DK1200561 T3 DK 1200561T3
Authority
DK
Denmark
Prior art keywords
cell clone
stabile
proteins
recombinant
preparation
Prior art date
Application number
DK99939251T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Mundt
Friedrich Dorner
Manfred Reiter
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3683861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1200561(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK1200561T3 publication Critical patent/DK1200561T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK99939251T 1999-08-05 1999-08-05 Rekombinant stabil celleklon, dens fremstilling og anvendelse DK1200561T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AT1999/000197 WO2001011021A1 (fr) 1999-08-05 1999-08-05 Clone cellulaire recombine stable, sa production et son utilisation

Publications (1)

Publication Number Publication Date
DK1200561T3 true DK1200561T3 (da) 2006-10-16

Family

ID=3683861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99939251T DK1200561T3 (da) 1999-08-05 1999-08-05 Rekombinant stabil celleklon, dens fremstilling og anvendelse

Country Status (11)

Country Link
EP (1) EP1200561B1 (fr)
JP (1) JP2003506077A (fr)
AT (1) ATE330003T1 (fr)
AU (1) AU780810B2 (fr)
CA (1) CA2381173A1 (fr)
CY (1) CY1106111T1 (fr)
DE (1) DE59913565D1 (fr)
DK (1) DK1200561T3 (fr)
ES (1) ES2267280T3 (fr)
PT (1) PT1200561E (fr)
WO (1) WO2001011021A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000517188A (ja) 1996-08-30 2000-12-26 ライフ テクノロジーズ，インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
DE60137950D1 (de) 2000-10-02 2009-04-23 Novo Nordisk Healthcare Ag Verfahren zur herstellung vitamin-k-abhängiger proteine
PL368119A1 (en) 2001-10-02 2005-03-21 Novo Nordisk Health Care Ag Method for production of recombinant proteins in eukaryote cells
EP1453948A2 (fr) * 2001-11-28 2004-09-08 Sandoz Gmbh Procede de culture de cellules
CA2468971A1 (fr) * 2001-12-04 2003-06-12 Mitsubishi Pharma Corporation Procede d'activation de proteine
AU2003249990B2 (en) 2002-07-09 2007-06-28 Takeda Pharmaceutical Company Limited Animal protein free media for cultivation of cells
US8669109B2 (en) 2003-08-19 2014-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methods of producing proteins in Chinese hamster ovary (CHO) cells
DE10338531A1 (de) * 2003-08-19 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Reklonierung von Produktionszellen
BRPI0417916A (pt) * 2003-12-31 2007-04-10 Merck Patent Gmbh proteìna de fusão de fc-eritropoietina com farmacocinética melhorada
US20060094104A1 (en) * 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
AU2011221414B2 (en) * 2004-10-29 2012-09-20 Takeda Pharmaceutical Company Limited Animal Protein-Free Media for Cultivation of Cells
ATE541919T1 (de) * 2005-02-11 2012-02-15 Novo Nordisk Healthcare Ag Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält
PT1974014T (pt) 2006-01-04 2017-05-26 Baxalta Inc Meios de cultura celulares livres de oligopeptídeos
CA2742107A1 (fr) * 2008-11-12 2010-05-20 Baxter International Inc. Procede de production de facteur vii sans insuline, sans serum
WO2024024671A1 (fr) * 2022-07-27 2024-02-01 不二製油グループ本社株式会社 Promoteur de la prolifération de cellules animales

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4313620A1 (de) * 1993-04-26 1994-10-27 Biotechnolog Forschung Gmbh Hamsterzellinien und Verfahren zur Glykoproteingewinnung
EP0666312A1 (fr) * 1994-02-08 1995-08-09 Wolfgang A. Renner Procédé pour l'amélioration de la croissance de cellules de mammifères
ES2378409T3 (es) * 1994-11-10 2012-04-12 Baxter Healthcare S.A. Método para producir sustancias biológicas en cultivo sin proteínas
WO1996018734A1 (fr) * 1994-12-16 1996-06-20 Novartis Ag Protection d'un constituant secretoire recombine
AUPN442295A0 (en) * 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein

Also Published As

Publication number Publication date
AU780810B2 (en) 2005-04-21
CY1106111T1 (el) 2011-06-08
AU5363699A (en) 2001-03-05
EP1200561B1 (fr) 2006-06-14
DE59913565D1 (de) 2006-07-27
ATE330003T1 (de) 2006-07-15
ES2267280T3 (es) 2007-03-01
JP2003506077A (ja) 2003-02-18
WO2001011021A1 (fr) 2001-02-15
CA2381173A1 (fr) 2001-02-15
PT1200561E (pt) 2006-09-29
EP1200561A1 (fr) 2002-05-02

Similar Documents

Publication Publication Date Title
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
HUP0101136A2 (hu) Fehérjeexpresszió baculovírus-vektort alkalmazó expressziós rendszerben
AU560340B2 (en) Rennin from recombinant dna
BR0107474A (pt) Preparação de proteìnas e permuteìnas desalergenizadas
DE69332981D1 (de) Methoden zur herstellung löslicher, oligomerer proteine
CA2095852A1 (fr) Proteines a mutation d'epitopes; procede de fabrication
GB2429211A (en) Feeder independent extended culture of embryonic stem cells
WO2000075350A3 (fr) Sequences d'acide nucleique codant des proteines impliquees dans la beta-oxydation des acides gras et procedes d'utilisation
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
HUP0303843A2 (hu) CLyA-hemolizin alkalmazása proteinek exkretáltatására
DE69636899D1 (de) Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
ES2059367T3 (es) Produccion de proteinas mediante cultivo de celulas.
KR890005272A (ko) 흉선 간질-유래 t세포 성장인자 및 그의 제조방법
DE69425809D1 (de) Methoden zur Herstellung von Protein C
TW200700553A (en) Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
ITRM920809A1 (it) Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
ATE168117T1 (de) Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung
LT2005053A (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
DE69923595D1 (de) Herstellung von proteinen
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
DE60033562D1 (de) Künstliche promotoren zür protein expression in pflanzen
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
NO933268L (no) Fremgangsmaate for fremstilling av protein fra udoedelige celler dyrket in vivo
JPS57202287A (en) Cultivation and preparation of urokinase by it
DK197091A (da) Fremgangsmaade til fremstilling af proteiner med fviii aktivitet og/eller fviii derivater